Avella Specialty Pharmacy is recalling 911 units of Bevacizumab 2.5 mg/0.1mL pre-filled syringes (deliverable dose of 1.25mg in a Normject syringe) because they may not be sterile. The lack of sterility assurance in an injectable drug can lead to serious health complications or infections. These repackaged syringes were distributed nationwide and include NDC 42852-001-24 with a specific lot number and beyond-use date. Consumers should contact their healthcare provider or pharmacist immediately to determine if they received this medication and to discuss next steps.
If a drug intended for injection lacks assurance of sterility, it may contain microorganisms that can cause severe infections or life-threatening inflammatory responses when administered.
Refund for unused product
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.